The target INR range for patients on warfarin therapy varies depending on their condition but is typically between 2.0 and 3.0.

Frequency of testing depends on individual patient needs, but initially, it may be done weekly or bi-weekly until stable, then less frequently thereafter.

Yes, the PT / INR Test can help diagnose various clotting disorders, including those related to liver disease or genetic clotting factor deficiencies.

Medications, dietary changes, liver function, and underlying health conditions can all influence PT / INR results.

Yes, the PT / INR Test is a safe and standard diagnostic procedure used worldwide to monitor blood clotting ability and adjust anticoagulant therapy.

Recovery time is typically shorter than traditional surgery. Most patients can return to normal activities within a few days to weeks.

The Anti-Cardiolipin Antibody Test detects antibodies against cardiolipin, aiding in the diagnosis of antiphospholipid syndrome (APS) and evaluating the risk of blood clots.

A blood sample is collected from your arm and analyzed for the presence of anti-cardiolipin antibodies.

No special preparation or fasting is required. You can eat and drink normally before the test.

Results are typically available within 1-2 days, depending on the laboratory’s processing time.

Discuss any abnormal results with your healthcare provider for guidance on further tests or treatment options based on your specific condition.